Cite
HARVARD Citation
Lopès, A. et al. (2020). Colibactin‐positive Escherichia coli induce a procarcinogenic immune environment leading to immunotherapy resistance in colorectal cancer. International journal of cancer. 146 (11), pp. 3147-3159. [Online].